RNU6-469P

Across TCGA pan-cancer cohorts, RNU6-469P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RNU6-469P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-469P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-469P expression acts as an unfavorable survival marker, although some lineages such as LUSC and LUAD show a favorable association.

ACC, ESCA, and CHOL are the cancer types where RNU6-469P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.292	0.684	<.001	87	view →
ESCA	OS	Tertile	IV	0.127	0.571	.003	69	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	63	view →
TGCT	DFS	Tertile	All	0.620	0.839	.003	54	view →
LUSC	OS	Tertile	II,III,IV	0.589	0.337	.003	54	view →
UCEC	OS	Tertile	IV	0.349	0.764	.002	36	view →
READ	OS	Tertile	II,III,IV	0.178	0.672	.006	27	view →
BLCA	DFS	Tertile	All	0.395	0.534	.022	18	view →
PAAD	OS	Tertile	All	0.435	0.628	.030	18	view →
DLBC	OS	Tertile	III,IV	0.172	1.000	.014	18	view →
LUAD	DFS	Tertile	All	0.862	0.769	.027	12	view →
GBM	OS	Tertile	All	0.281	0.436	.030	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RNU6-469P–ACC (OS)

Open the ACC breakdown →